Agenus (AGEN) Non Operating Income (2010 - 2026)

Agenus' (AGEN) quarterly Non Operating Income came in at -$208000.0 in Q1 2026, up 21.21% year-on-year from -$171600.0 in Q1 2025, and up 99.42% quarter-over-quarter from -$35.7 million in Q4 2025.

Agenus (AGEN) Non Operating Income (2010 - 2026) Analysis & Trends

Agenus' Non Operating Income history runs 17 years deep, the most recent figure standing at -$208000.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 21.21% year-over-year to -$208000.0 in Q1 2026; TTM through Mar 2026 was -$55.2 million, a 71.15% increase from a year earlier, with the FY2025 full-year figure at -$55.3 million, up 53.01% from the prior year.
  • Non Operating Income rose to -$208000.0 in Q1 2026 per AGEN's latest filing, from -$35.7 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $9.1 million in Q2 2022 and bottomed at -$123.7 million in Q4 2024.
  • The 5-year median for Non Operating Income is -$17.3 million (2022), against an average of -$24.5 million.
  • Across the five-year window, Non Operating Income soared 1084.89% in 2022 and tumbled 73765.0% in 2024, its largest moves.
  • Year by year, Non Operating Income stood at -$17.3 million in 2022, then tumbled by 466.6% to -$98.2 million in 2023, then slipped by 25.99% to -$123.7 million in 2024, then soared by 71.14% to -$35.7 million in 2025, then surged by 99.42% to -$208000.0 in 2026.
  • Per Business Quant, the three latest AGEN Non Operating Income figures stand at -$208000.0 (Q1 2026), -$35.7 million (Q4 2025), and -$19.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn -208,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -208,000.00
Dec 31, 2025 -35.70 Mn
Sep 30, 2025 -19.30 Mn
Jun 30, 2025 -12,000.00
Mar 31, 2025 -264,000.00
Dec 31, 2024 -123.68 Mn
Sep 30, 2024 -35.73 Mn
Jun 30, 2024 -31.75 Mn
Mar 31, 2024 -29.47 Mn
Dec 31, 2023 -98.16 Mn
Sep 30, 2023 -18.63 Mn
Jun 30, 2023 -244,000.00
Mar 31, 2023 40,000.00
Dec 31, 2022 -17.33 Mn
Sep 30, 2022 537,000.00
Jun 30, 2022 9.06 Mn
Mar 31, 2022 -15.20 Mn
Dec 31, 2021 54.20 Mn
Sep 30, 2021 121,000.00
Jun 30, 2021 -920,000.00